Cost effectiveness thresholds: the past, the present and the future
作者： Praveen Thokala , Jessica Ochalek , Ashley A. Leech , Thaison Tong
DOI: 10.1007/S40273-017-0606-1
关键词: Econometrics 、 Heuristic 、 Cost effectiveness 、 Quality of Life Research 、 Value (mathematics) 、 Demand side 、 Multiple criteria 、 Computer science 、 Supply side 、 Divisibility rule
摘要: Cost-effectiveness (CE) thresholds are being discussed more frequently and there have been many new developments in this area; however, is a lack of understanding about what mean their implications. This paper provides an overview the CE threshold literature. First, meaning key assumptions involved (perfect divisibility, marginal increments budget, etc.) highlighted using hypothetical example, use historic/heuristic estimates noted along with limitations. Recent endeavours to estimate empirical value thresholds, both from supply side demand side, then presented. The impact on future directions for field, such as across sectors incorporation multiple criteria beyond quality-adjusted life-years measure ‘value’, highlighted. Finally, number common issues misconceptions associated addressed.
springer.com
core.ac.uk 
sci-hub.se 参考文章(65)
Karl Claxton, Steve Martin, Marta Soares, Nigel Rice, Eldon Spackman, Sebastian Hinde, Nancy Devlin, Peter C Smith, Mark Sculpher, Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold Health Technology Assessment. ,vol. 19, pp. 1- 504 ,(2015) , 10.3310/HTA19140
Elizabeth Griffiths, Janek Hendrich, Sean Walsh, Samuel Stoddart, Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold ClinicoEconomics and Outcomes Research. ,vol. 7, pp. 463- 476 ,(2015) , 10.2147/CEOR.S87462
Peter J Neumann, Gillian D Sanders, Louise B Russell, Joanna E Siegel, Theodore G Ganiats, None, Cost-effectiveness in health and medicine Oxford University Press. ,(1996)
Karl Claxton, Mark Sculpher, Stephen Palmer, Anthony J Culyer, CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? Health Economics. ,vol. 24, pp. 1- 7 ,(2015) , 10.1002/HEC.3130
Ruth Schwarzer, Ursula Rochau, Kim Saverno, Beate Jahn, Bernhard Bornschein, Nikolai Muehlberger, Magdalena Flatscher-Thoeni, Petra Schnell-Inderst, Gaby Sroczynski, Martina Lackner, Imke Schall, Ansgar Hebborn, Karl Pugner, Andras Fehervary, Diana Brixner, Uwe Siebert, None, Systematic overview of cost-effectiveness thresholds in ten countries across four continents Journal of Comparative Effectiveness Research. ,vol. 4, pp. 485- 504 ,(2015) , 10.2217/CER.15.38
Praveen Thokala, Simon Dixon, Beate Jahn, Resource Modelling: The Missing Piece of the HTA Jigsaw? PharmacoEconomics. ,vol. 33, pp. 193- 203 ,(2015) , 10.1007/S40273-014-0228-9
Thavorncharoensap, Teerawattananon, Sirin Natanant, Kulpeng, Yothasamut, Pitsaphun Werayingyoung, Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? ClinicoEconomics and Outcomes Research. ,vol. 5, pp. 29- 36 ,(2013) , 10.2147/CEOR.S38062
Simon Eckermann, Brita Pekarsky, Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room PharmacoEconomics. ,vol. 32, pp. 319- 325 ,(2014) , 10.1007/S40273-014-0140-3
Steven Simoens, Health Economic Assessment: A Methodological Primer International Journal of Environmental Research and Public Health. ,vol. 6, pp. 2950- 2966 ,(2009) , 10.3390/IJERPH6122950
David M. Epstein, Zaid Chalabi, Karl Claxton, Mark Sculpher, Efficiency, equity, and budgetary policies: informing decisions using mathematical programming. Medical Decision Making. ,vol. 27, pp. 128- 137 ,(2007) , 10.1177/0272989X06297396